Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ExPANdS Resource Report Resource Website 500+ mentions |
ExPANdS (RRID:SCR_005199) | ExPANdS | software resource | Software that characterizes coexisting subpopulations (SPs) in a tumor using copy number and allele frequencies derived from exome- or whole genome sequencing input data. The model amplifies the statistical power to detect coexisting genotypes, by fully exploiting run-specific tradeoffs between depth of coverage and breadth of coverage. ExPANdS predicts the number of clonal expansions, the size of the resulting SPs in the tumor bulk, the mutations specific to each SP and tumor purity. The main function runExPANdS provides the complete functionality needed to predict coexisting SPs from single nucleotide variations (SNVs) and associated copy numbers. The robustness of the subpopulation predictions by ExPANdS increases with the number of mutations provided. It is recommended that at least 200 mutations are used as an input to obtain stable results. | copy number, allele, frequency, exome, whole genome, sequencing, ploidy, subpopulation, genotype, mutation, single nucleotide variation |
is listed by: OMICtools has parent organization: University of California at San Francisco; California; USA |
Tumor | PMID:24177718 | GNU General Public License, v2 | OMICS_00218 | SCR_005199 | Expanding Ploidy and Allele Frequency on Nested Subpopulations | 2026-07-25 12:06:00 | 907 | |||||
|
SomaticSniper Resource Report Resource Website 100+ mentions |
SomaticSniper (RRID:SCR_005108) | SomaticSniper | software resource | Software program to identify single nucleotide positions that are different between tumor and normal (or, in theory, any two bam files). It takes a tumor bam and a normal bam and compares the two to determine the differences. It outputs a file in a format very similar to Samtools consensus format. It uses the genotype likelihood model of MAQ (as implemented in Samtools) and then calculates the probability that the tumor and normal genotypes are different. This probability is reported as a somatic score. The somatic score is the Phred-scaled probability (between 0 to 255) that the Tumor and Normal genotypes are not different where 0 means there is no probability that the genotypes are different and 255 means there is a probability of 1 ? 10(255/-10) that the genotypes are different between tumor and normal. This is consistent with how the SAM format reports such probabilities. It is currently available as source code via github or as a Debian APT package. |
is listed by: OMICtools has parent organization: Washington University in St. Louis; Missouri; USA |
Cancer, Tumor, Normal | PMID:22155872 | Acknowledgement requested | OMICS_00092 | SCR_005108 | 2026-07-25 12:06:01 | 146 | |||||||
|
SomaticIndelDetector Resource Report Resource Website 50+ mentions |
SomaticIndelDetector (RRID:SCR_005107) | SomaticIndelDetector | software resource | Tool for calling indels in Tumor-Normal paired sample mode. | cancer-specific variant discovery tool, variant, tumor, normal, bam, indel |
is listed by: OMICtools has parent organization: Broad Institute |
Cancer, Tumor, Normal | OMICS_00091 | SCR_005107 | 2026-07-25 12:05:59 | 81 | ||||||||
|
Capital Biosciences Resource Report Resource Website 1+ mentions |
Capital Biosciences (RRID:SCR_004879) | commercial organization | Biological products including Cell Immortalization Products, Clinically Defined Human Tissue, cDNA ORF Clones, Premade Adenoviruses, Purified Proteins, Viral Expression Systems and others as well as services like Custom Recombinant Adenovirus Production, Custom Recombinant Lentivirus Production, Protein Detection and Quantification and Stable Cell Line Production for academic and governmental research institutes, pharmaceutical and biotechnology industry. Capital Biosciences offers most types of human tissues, normal and diseased, with extensive clinical history and follow up information. Standard specimen format: Snap-frozen(flash-frozen), Formalin fixed and paraffin embedded (FFPE) tissues, Blood and blood products, Bone marrow, Total RNA, Genomic DNA, Total Proteins, Primary cell cultures, Viable frozen tissue. Tumor tissue samples include: Bladder cancer, Glioblastoma, Medulloblastoma, Breast Carcinoma, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Head and Neck (H&N) Carcinoma, Hepatocellular Carcinoma (HCC), Hodgkin's lymphoma, Kidney, Renal Cell Carcinoma, Lung Cancer, Non-Small Cell (NCSLC), Lung Cancer, Small Cell (SCLC), Melanoma, Mesothelioma, non-Hodgkin's Lymphoma, Ovarian Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Stomach Cancer. | cell immortalization, clinical, tissue, cdna orf clone, premade adenovirus, purified protein, viral expression, recombinant adenovirus, recombinant lentivirus, protein, detection, quantification, cell line, disease, formalin fixed and paraffin embedded, frozen, tissue, blood, blood product, bone marrow, rna, dna, protein, cell culture, tumor tissue | is listed by: One Mind Biospecimen Bank Listing | Normal, Cancer, Tumor, Bladder cancer, Glioblastoma, Medulloblastoma, Breast Carcinoma, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Head Carcinoma, Neck Carcinoma, Hepatocellular Carcinoma, Hodgkin's lymphoma, Kidney, Renal Cell Carcinoma, Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell, Melanoma, Mesothelioma, Non-Hodgkin's Lymphoma, Ovarian Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Stomach Cancer | nlx_85333 | http://www.capitalbiosciences.com/category/show/tissue-human-clinically-defined.html | SCR_004879 | Capital Biosciences: innovative solutions for life sciences, Capital Biosciences Inc. | 2026-07-25 12:05:55 | 2 | |||||||
|
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology Resource Report Resource Website |
UMAS University Hospital - Biobanks of the Department of Clinical Pathology and Cytology (RRID:SCR_005957) | Biobanks of the Department of Clinical Pathology and Cytology | instrument supplier, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 6th, 2022. The biobank comprises paraffin blocks of surgical and autopsy tissue samples and corresponding histological slides as well as cytological material consisting of slides of vaginal smears, fine needle aspiration biopsies and exfoliative cytological material. The tissue samples date back until 1944 and most of the cytological samples until 1970. A subunit of the bank constitutes the National Tissue Microarray Centre. This center is supported by SWEGENE with the purpose to organize and construct tissue microarrays (TMA:s) for high throughput molecular pathology research on various kinds of tumors and other diseases. By linking the TMA.s to long-term and complete clinical follow-up data, prognostic and predictive studies will be facilitated. Biobank content: * Approximately 2,4 million paraffin blocks of surgical tissue specimens, * 1,1 million paraffin blocks of tissue samples from autopsies, * 3,8 million histological slides and * 1,6 million cytology slides. At present, the Tissue Microarray Centre includes: * A consecutive series of all invasive breast cancers (n=600) diagnosed in Malmo between 1988 and 1992. * All incident breast cancers within the Malmo Diet and Cancer cohort (n=400). * A subgroup of 600 pre-menopausal primary breast cancers within the nationwide, population-based randomized tamoxifen trial SBII:2. * 180 primary breast cancers from post-menopausal women included in a similar study. * A set of 120 extremely well characterized primary breast cancer samples with a clinical follow-up of 10 years. More than 40 relevant tumor biological parameters have been recorded in this material and it is therefore useful for a first screening of a marker in order to identify associations to other gene products. * 350 renal cell carcinomas (In collaboration with NUS). We provide researchers with state-of-the-art population based tissue microarrays with long-term and complete follow-up data on survival and treatment. With the TMA-technology, valuable biobank material will be preserved, allowing high throughput in-situ analyses of various tumors and other diseases with a minimal waste of tissue. | surgery, autopsy, histology slide, vaginal smear, fine needle aspiration, biopsy, tissue microarray, tumor, disease, cancer, diet, renal cell, kidney |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Swedish National Biobank Program |
Breast cancer, Cancer, Tumor, Carcinoma | SWEGENE | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_151315 | SCR_005957 | UMAS University Hospital - Biobanks of the Department of Clinical Pathology Cytology | 2026-07-25 12:13:25 | 0 | |||||
|
Chernobyl Tissue Bank Resource Report Resource Website 1+ mentions |
Chernobyl Tissue Bank (RRID:SCR_010662) | CTB | biomaterial supply resource, material resource | The CTB (Chernobyl Tissue Bank) is an international cooperation that collects, stores and disseminates biological samples from tumors and normal tissues from patients for whom the aetiology of their disease is known - exposure to radioiodine in childhood following the accident at the Chernobyl power plant. The main objective of this project is to provide a research resource for both ongoing and future studies of the health consequences of the Chernobyl accident. It seeks to maximize the amount of information obtained from small pieces of tumor by providing multiple aliquots of RNA and DNA extracted from well documented pathological specimens to a number of researchers world-wide and to conserve this valuable material for future generations of scientists. It exists to promote collaborative, rather than competitive, research on a limited biological resource. Tissue is collected to an approved standard operating procedure (SOP) and is snap frozen; the presence or absence of tumor is verified by frozen section. A representative paraffin block is also obtained for each case. Where appropriate, we also collect fresh and paraffin-embedded tissue from loco-regional metastases. Currently we do not issue tissue but provide extracted nucleic acid, paraffin sections and sections from tissue microarrays from this material. The project is coordinated from Imperial College, London and works with Institutes in the Russian Federation (the Medical Radiological Research Centre in Obninsk) and Ukraine (the Institute of Endocrinology and Metabolism in Kiev) to support local scientists and clinicians to manage and run a tissue bank for those patients who have developed thyroid tumors following exposure to radiation from the Chernobyl accident. Belarus was also initially included in the project, but is currently suspended for political reasons. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Imperial College London; London; United Kingdom |
Tumor, Normal, Exposure to radioiodine in childhood following the accident at the Chernobyl power plant | European Union ; Sasakawa Memorial Health Foundation ; NCI |
nlx_70828 | SCR_010662 | 2026-07-25 12:12:52 | 9 | ||||||||
|
The Cancer Genome Atlas Resource Report Resource Website 5000+ mentions |
The Cancer Genome Atlas (RRID:SCR_003193) | TCGA | biomaterial supply resource, material resource | Project exploring the spectrum of genomic changes involved in more than 20 types of human cancer that provides a platform for researchers to search, download, and analyze data sets generated. As a pilot project it confirmed that an atlas of changes could be created for specific cancer types. It also showed that a national network of research and technology teams working on distinct but related projects could pool the results of their efforts, create an economy of scale and develop an infrastructure for making the data publicly accessible. Its success committed resources to collect and characterize more than 20 additional tumor types. Components of the TCGA Research Network: * Biospecimen Core Resource (BCR); Tissue samples are carefully cataloged, processed, checked for quality and stored, complete with important medical information about the patient. * Genome Characterization Centers (GCCs); Several technologies will be used to analyze genomic changes involved in cancer. The genomic changes that are identified will be further studied by the Genome Sequencing Centers. * Genome Sequencing Centers (GSCs); High-throughput Genome Sequencing Centers will identify the changes in DNA sequences that are associated with specific types of cancer. * Proteome Characterization Centers (PCCs); The centers, a component of NCI's Clinical Proteomic Tumor Analysis Consortium, will ascertain and analyze the total proteomic content of a subset of TCGA samples. * Data Coordinating Center (DCC); The information that is generated by TCGA will be centrally managed at the DCC and entered into the TCGA Data Portal and Cancer Genomics Hub as it becomes available. Centralization of data facilitates data transfer between the network and the research community, and makes data analysis more efficient. The DCC manages the TCGA Data Portal. * Cancer Genomics Hub (CGHub); Lower level sequence data will be deposited into a secure repository. This database stores cancer genome sequences and alignments. * Genome Data Analysis Centers (GDACs) - Immense amounts of data from array and second-generation sequencing technologies must be integrated across thousands of samples. These centers will provide novel informatics tools to the entire research community to facilitate broader use of TCGA data. TCGA is actively developing a network of collaborators who are able to provide samples that are collected retrospectively (tissues that had already been collected and stored) or prospectively (tissues that will be collected in the future). | genome, genome sequencing, breast, central nervous system, endocrine, gastrointestinal, gynecologic, head, neck, hematologic, skin, soft tissue, thoracic, urologic, clinical, genomic characterization, analysis, tumor genome, demographic, gene expression, copy number alteration, epigenetic, dna sequence, exome, snp, methylation, mrna, mirna, FASEB list |
is used by: Mutation Annotation and Genomic Interpretation is used by: BioXpress is used by: cancerRxTissue is listed by: One Mind Biospecimen Bank Listing is related to: Cancer3D is related to: Cancer Research Data Commons is related to: CancerMIRNome is related to: Broad Institute Genomics Platform has parent organization: National Cancer Institute works with: FireBrowse |
Cancer, Tumor, Normal, Breast cancer, Central Nervous System cancer, Endocrine cancer, Gastrointestinal cancer, Gynecologic cancer, Head cancer, Neck cancer, Hematologic cancer, Skin cancer, Soft tissue cancer, Thoracic cancer, Urologic cancer | NCI 261200800001E-12-0-1 | nlx_156913 | SCR_003193 | Cancer Genome Atlas | 2026-07-25 12:12:27 | 6292 | ||||||
|
Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource Resource Report Resource Website 1+ mentions |
Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource (RRID:SCR_004626) | HCC Tissue Biorepository | cell repository, biomaterial supply resource, material resource | The Hollings Cancer Center Tissue Biorepository & Research Pathology Services Shared Resource provides investigators with a centralized infrastructure that promotes biomedical research involving the use and study of human biospecimens. The shared resource is comprised of four integrated components: Biospecimens and data bank, Laser Capture Microdissection, Tissue Microarray, and Research Pathology Services. These components, along with extensive staff expertise, offer a comprehensive means by which researchers can utilize valuable human biospecimens and cutting edge technology to support basic, translational and clinical research. Services: * Biospecimen and Data Bank ** Collecting, processing, and banking of tissue, saliva, urine, blood, plasma, serum, and other tissue derivatives; including those for protocol driven studies ** Retrieval of banked specimens linked to clinicopathologic data, while maintaining patient confidentiality, for research use ** Quality control of collected tissue by the Tissue Biorepository Director, a trained pathologist: verification of diseased state and assessment of tumor purity, etc ** Quality control of DNA/RNA/protein isolated from collected tissue using the Agilent Bioanalyzer * Laser Capture Microdissection ** Identification, localization, and microdissection of targeted cell populations (from human and animal tissue sources) ** Extraction of DNA/RNA/protein from microdissected samples. ** Quality analysis and quality control of isolated nucleic acid using Agilent Bioanalyzer * Tissue Microarray ** Create custom and standard TMAs ** Consultation and technical support in the construction and analyses of TMA * Research Pathology Services ** Macrodissection of tissue prior to isolation of DNA/RNA/protein to increase tumor purity ** Immunohistochemistry and In-situ hybridization ** Quantitative image analysis on conventional and TMA sections, including tissue scoring, Ki-67 labeling index, microvascular density counting, and tissue microarray scoring, etc. * Bio-molecular Assessment ** Cellular DNA, RNA and protein prepared by the Tissue Repository from banked specimens or any other biomolecules submitted by investigators can be qualitatively assessed by Agilent Bioanalyzer, prior to use for downstream applications such as microarray and/or qRT-PCR analysis | cancer, leukemia, lymphoma, myeloma, solid tumor, tumor, tissue, saliva, urine, blood, plasma, serum, dna, rna, protein, clinicopathologic data, immunohistochemistry, in-situ hybridization, macrodissection, tissue microarray, paraffin, frozen, oct embedded, block, h & e staining, slide, malignant, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical University of South Carolina; South Carolina; USA |
Cancer, Leukemia, Lymphoma, Myeloma, Solid tumor, Tumor | Public: Prices listed for HCC, MUSC, And outside MUSC. | nlx_62775 | http://hcc.musc.edu/research/sharedresources/biorepository/index.htm | SCR_004626 | Hollings Cancer Center Tissue Biorepository Research Pathology Services Shared Resource | 2026-07-27 09:32:05 | 2 | |||||
|
GSE1456 Resource Report Resource Website 100+ mentions |
GSE1456 (RRID:SCR_003642) | GSE1456 | data or information resource, data set | Curated series of expression data for 159 tumors from which RNA could be collected in sufficient amounts and quality for analysis from breast cancer patients. Tissue material was collected from all breast cancer patients receiving surgery at Karolinska Hospital from 1994-1996. | adult human, breast |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Breast cancer, Tumor | Free, Public | nlx_157793 | SCR_003642 | 2026-07-27 09:31:49 | 184 | |||||||
|
Target genes of Wnt/beta-catenin signaling Resource Report Resource Website 10+ mentions |
Target genes of Wnt/beta-catenin signaling (RRID:SCR_007022) | Target genes of Wnt/beta-catenin signaling | data or information resource, data set | A list of target genes of Wnt/beta-catenin signaling. Suggestions for additions are welcome. Direct targets are defined as those with Tcf binding sites and demonstrating that these sites are important. | target gene, wnt/beta-catenin signaling, wnt, beta-catenin, signaling, gene | has parent organization: Stanford University; Stanford; California | Colon cancer, Tumor, Adenocarcinoma, Melanoma, Cancer | The community can contribute to this resource | nlx_156867 | SCR_007022 | 2026-07-27 09:32:43 | 24 | |||||||
|
UCSF Brain Tumor Tissue Bank Resource Report Resource Website |
UCSF Brain Tumor Tissue Bank (RRID:SCR_000647) | tissue bank, biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 4th,2023. Brain Tumor Research Center Tissue Bank began collecting tissue in 1978 and has established an organized repository of characterized tissues--frozen, paraffin-embedded, blood and cultures--that are maintained in a manner useful for a wide range of studies. Samples are collected only from patients who have agreed to have their tissues banked and used for future research. Consent documents are maintained in a secure area and associated clinical data are held in a double-password protected computer database. Each sample received into the Tissue Bank is non-identifying number. No protected health information (PHI) is released. To obtain samples, investigators submit a request form to the Manager. The request form requires an explanation of the tissue requested (type, number of samples, justification), description of the study, CHR approval (see new policy regarding human vs. non-human research) and Project Leader authorization. The Manager reviews each request for feasibility before presentation to the Scientific Core Committee. The UCSF Neurosurgery Tissue Bank makes its inventory of stock cell lines available to all investigators. Requested cells are grown in T-25 flasks and shipped FedEx Priority Overnight at the receipient's expense. However, if you prefer, we can ship the frozen cells, packed in dry ice. (Note: some countries restrict dry ice shipments.) | tissue, frozen, paraffin-embedded, blood, culture, frozen tissuefrozen serum, serum, paraffin embedded tissue, research, cell, cell line |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of California at San Francisco; California; USA |
Tumor | NINDS P01 NS94297; NCI P-50-CA97257 |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_33528, SCR_006439, nlx_143683 | https://gnome.ucsf.edu/tbank/ | SCR_000647 | UCSF Brain Tumor Research Center Tissue Bank, UCSF Brain Tumor Research Center Tissue Core, UCSF Neurosurgery Tissue Bank, UCSF Neurological Surgery Tissue Bank, UCSF BTRC Tissue Core | 2026-07-28 09:40:04 | 0 | |||||
|
Southampton Tumour Bank Resource Report Resource Website |
Southampton Tumour Bank (RRID:SCR_000673) | Southampton Tumour Bank | tissue bank, biomaterial supply resource, material resource | Collects and distributes human tissue for ethically approved studies to aid the study of cancer biology and other associated research. All tissue is collected with patient consent and tissue is distributed only to ethically approved studies. The purpose of the Tissue Bank is to source, organize, collect, prepare, store and distribute a diverse collection of human tissues and biological products. This valuable core resource is available to all local academics and researchers. The on-site bank allows for rapid access to a plethora of biological materials supported by an informatics system of databases acting as an inventory management system. In addition, the Tissue Bank provides a licensed facility to store surplus tissue when studies close. Tissues currently available include normal and malignant snap frozen blocks, freshly prepared spleen and lymph nodes, fresh biopsy tissues, blood products and biological fluids. Collections can be organized by bank staff or ran in parallel with current research activities and include a wide variety of cancer classifications. We currently hold over 38,000 vials. Tissue Availability: Lymphoma - solid tissue and cells - 843; Breast - solid tissue and cells - 540; Colon - solid tissue and cells - 238; Lung - solid tissue and cells - 43; Upper Gi - BIOPSY tissue - 114; Pleural fluid and cells - 14 | cancer biology, cancer, tumor, blood product, biological fluid, tissue, spleen, lymph node, biopsy tissue, blood product, bodily fluid, blood, lymphoma, solid tissue, cell, breast, colon, lung, upper gastrointestinal, pleural fluid, gastrointestinal |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Southampton; Southampton; United Kingdom |
Cancer, Tumor, Normal, Malignant | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_14010 | http://www.som.soton.ac.uk/research/facilities/cruk/infrastructure/tumour_bank/default.htm | SCR_000673 | University of Southampton Tumour Bank, University of Southampton Tumor Bank, University of Southampton Cancer Research UK Centre Tumour Bank, Southampton Tumor Bank, Cancer Research UK Centre Tumour Bank, Cancer Research UK Center Tumor Bank | 2026-07-28 09:40:02 | 0 | |||||
|
OECI - Tubafrost: The European Human Frozen Tissue Bank Resource Report Resource Website 1+ mentions |
OECI - Tubafrost: The European Human Frozen Tissue Bank (RRID:SCR_004280) | Tubafrost | tissue bank, biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 9, 2023. In this web site you will find the central European database of OECI-TuBaFrost collecting the information of biobanks or in the project support environment on human material; i.e., frozen tumor tissue specimens, pathology blocks, blood samples in different forms, cell lines, Tissue Micro Arrays, etc. Our goal is by centralizing the tumor tissues information to facilitate the search of doctors / researchers for tumor materials, which they need for their cancer research there with facilitating cancer research. OECI members only can participate in the OECI-TuBaFrost exchange platform, or those introduced by an OECI member. We are a group of pathology and research departments as well as bio-bankers in clinical based biobanking based in comprehensive cancer centers or hospitals with a competence in comprehensive cancer care across Europe. Each participating institute is involved in cancer research resulting in innovative procedures, new drugs, improved diagnosis and new insights in disease development. The overall result is better care and treatment for cancer patients. To maximize the scientific value of the human tissue samples, information about the clinical status of the patient in combination with the quality and type of samples is very important. A TuBaFrost electronic database will securely store all this information. Within the closed project supporting environments, the data collected will include: * Diagnosis - identification of the type of cancer * Type of tissue collected - the origin, i.e. breast, skin, colorectal * Quality of tissue collected - collection and storage details The tissue is stored in the hospital where the donor was diagnosed/treated. It stays there until it is used or sent to another hospital or research center within the TuBaFrost group. The electronic database will track samples throughout the network. The tissue is not sold. The exchange of tissue to other hospitals is regulated by a contract, which uses the national regulations of the country supplying the tissue. Tissue samples within the TuBaFrost collection will only be used for research, which has been approved by ethics committees. This ensures that the tissue is only used for the best quality research and only for the specific reasons given to the ethics committee. | tumor tissue, blood, cell line, tissue, frozen, block, tissue micro array, tumor, cancer, clinical, clinical data |
is listed by: One Mind Biospecimen Bank Listing has parent organization: OECI - Organisation for European Cancer Institutes |
Tumor, Cancer | European Union | PMID:18564601 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_36384 | SCR_004280 | OECI-TuBaFrost database, TuBaFrost biobank, Tubafrost Central Database, OECI TuBaFrost, Tubafrost - The European Human Frozen Tissue Bank, OECI-TuBaFrost | 2026-07-28 09:40:56 | 2 | ||||
|
Case Comprehensive Cancer Center Biorepository and Tissue Processing Core Facility Resource Report Resource Website |
Case Comprehensive Cancer Center Biorepository and Tissue Processing Core Facility (RRID:SCR_004382) | BTPC | tissue bank, biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 11, 2023. The Case Comprehensive Cancer Center''s Biorepository and Tissue Processing Core Facility (BTPC) serves two primary functions: 1. To build an inventory of remnant human tissues, blood and other body fluids (collectively termed biospecimens) targeted towards cancer and other medical research, for later assignment to investigators; and 2. To provide long term, controlled storage of biospecimens for specific researchers. These samples are for research purposes only and may not be used for clinical diagnosis or implantation into humans. Clinical information relating to the samples and donors are collected and maintained in a secure database. Samples and data are de-identified or de-linked before release to the researcher unless he/she has specific IRB approval to gain access to this information. Remnant biospecimens are prospectively collected from surgical procedures, autopsies and clinical laboratories for the BTPC by the Human Tissue Procurement Facility (HTPF), which operates under UH-IRB Protocol 01-02-45. Blood and bone marrow specimens are collected for the BTPC by the Hematopoietic Stem Cell Core Facility (HSCC), which operates under UH-IRB Protocol 09-90-195. The Division of Surgical Pathology at University Hospitals Case Medical Center (UHCMC) has clinical archives of paraffin blocks that can be made available through the BTPC for retrospective research studies under the approval of the Vice Chair for Clinical Affairs at UHCMC. Surgical Pathologists associated with the BTPC are responsible for determining which blocks can be made available and how much material can be removed from the blocks. Types of Tissue Available * Malignant, benign, diseased, normal and normal human tissues * Normal adjacent tissues available paired with tumor specimens in many cases * Tissues are collected from over 50 anatomic sites * Frozen specimens, OCT-embedded and paraffin-embedded tissues * Large array of paraffin-embedded specimens from clinical archives of paraffin blocks and QC research blocks maintained by the HTPF * Peripheral blood and bone marrow samples from initial visits and follow-up procedures are processed to obtain serum and cell fractions for storage * No samples are collected from individuals with known infectious illnesses * Fetal biospecimens are not collected due to state and local statutes | tissue, blood, body fluid, bone marrow, stem cell, serum, cell fraction, paraffin block, clinical data, malignant tissue, benign tissue, diseased tissue, normal tissue, cancer, control, research, frozen, oct-embedded, paraffin-embedded, tumor, paraffin, oct |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Case Western Reserve University Case Comprehensive Cancer Center |
Cancer, Control, Tumor | NCI P30 CA43703 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_39515 | http://cancer.case.edu/sharedresources/biorepository/ | SCR_004382 | Case Western Biorepository, Case Western Reserve University: Biorepository and Tissue Processing Core Facility, CWRU BTPC, Biorepository and Tissue Processing Core Facility of the Case Comprehensive Cancer Center, Case BTPC, Case Comprehensive Cancer Center Biorepository Tissue Processing Core Facility, Case CCC BTPC, Case Comprehensive Cancer Center Biorepository and Tissue Processing Core Facility, Biorepository Tissue Processing Core Facility, Case Western Biorepository and Tissue Processing Core Facility, CWRU CCC Biorepository Tissue Processing Core Facility, Case CCC Biorepository Tissue Processing Core Facility | 2026-07-28 09:40:58 | 0 | ||||
|
My Cancer Genome Resource Report Resource Website 50+ mentions |
My Cancer Genome (RRID:SCR_004140) | MCG | data or information resource, database | A freely available online personalized cancer medicine knowledge resource for physicians, patients, caregivers and researchers that gives up-to-date information on what mutations make cancers grow and related therapeutic implications, including available clinical trials. It is a one-stop tool that matches tumor mutations to therapies, making information accessible and convenient for busy clinicians. | genome, disease, genome, medicine, clinical trial, mutation, therapy, FASEB list |
is listed by: OMICtools has parent organization: Vanderbilt University; Tennessee; USA |
Cancer, Tumor | PMID:32483629 | OMICS_01552 | SCR_004140 | MyCancerGenome.org | 2026-07-28 09:40:53 | 97 | ||||||
|
START Tumor Bank Resource Report Resource Website |
START Tumor Bank (RRID:SCR_004258) | START Tumor Bank | tissue bank, biomaterial supply resource, material resource | Biospecimen repository for tumor specimens, available to all researchers actively engaged in cancer research whether they are in University, Academic, or Pharmaceutical industry, with a goal to accelerate the discovery and development of new agents for the treatment and cure of cancer. The START tumor bank was created to make tumor tissue gifted by patients receiving care or treatment at The START Center available to all researchers involved in developing a better understanding of the biology of cancer or those engaged in the discovery of new therapies. The START Tumor Bank is a department within the PK Department and handles skin and tumor biopsies required by clinical trial protocols. A member of the PK Department is present during biopsy procedures for immediate processing of the sample for the trial. Additionally, the Tumor Bank collects and banks the tumor tissues of patients who consent. This tissue is then stored for future use by researchers developing new therapies. | tumor, cancer, tissue, tumor tissue, skin |
is listed by: One Mind Biospecimen Bank Listing has parent organization: South Texas Accelerated Research Therapeutics |
Tumor, Cancer | Public: The mission of the START tumor bank is to make available tumor specimens to all researchers actively engaged in cancer research whether they are in University, Academic, Or Pharmaceutical industry, With a goal to accelerate the discovery and development of new agents for the treatment and cure of cancer. | nlx_27097 | http://www.startthecure.com/preclinical-research.html | SCR_004258 | South Texas Tumor Bank, South Texas Accelerated Research Therapeutics Tumor Bank | 2026-07-28 09:40:55 | 0 | |||||
|
University of Rochester Program for Brain Tumors and Spinal Tumors Resource Report Resource Website |
University of Rochester Program for Brain Tumors and Spinal Tumors (RRID:SCR_005343) | URMC Program for Brain and Spinal Tumors, | brain bank, tissue bank, biomaterial supply resource, material resource | Collaborative neuro-oncology research program with a tissue repository (tumor bank) containing a wide range of clinical specimens, which they make available to researchers in order to study the effects of new drugs on a large number and wide range of tumor specimens. They provide highly coordinated, complex care in neurosurgery, radiation oncology, medical oncology, and neurology to patients afflicted with tumors of the brain and spine by combining the newest technologies and treatments available anywhere in the world. The program is formed from a multidisciplinary group with a goal of helping patients navigate the complex issues surrounding brain and spinal cancer care. The researchers are working to increase the number of targets that could be considered for anti-angiogenesis therapy. Many of their studies focus on the blood vessel cells (endothelial cells) themselves, which, unlike tumor cells, rarely mutate and so might be less likely to become resistant to therapy and are also more easily reached through the bloodstream. Their researchers are also attempting to better understand the changes in the blood-brain barrier (BBB) that are associated with fluid accumulation and brain swelling (edema) in neuro-oncology patients. Normal brain tissue is shielded from the rest of the body by the BBB. This barrier is composed of very tight blood vessels that prevent most substances from entering the brain. Brain tumors have a leaky BBB ����?? this feature can be used to identify tumors on MRI scans. They have identified specific molecules that appear to be associated with the leaky, abnormal vessels while the normal blood vessels with intact BBB produce these molecules at very low levels or not at all. Inhibiting the function of these molecules may help control or prevent disruption of the BBB and limit cerebral edema in brain tumor patients, as well as patients suffering from stroke or traumatic brain injury. | brain tissue, brain, tissue, spine, spinal tumor, brain tumor, tumor, cancer, normal control, clinical trial, treatment, acoustic neuroma, anaplastic astrocytoma, brain metastases, brain stem glioma, chordoma, cns lymphoma, craniopharyngioma, ependymoma, gliomatosis cerebri, glioblastoma, low grade glioma, meningioma, medulloblastoma, oligodendroglioma, pineal tumor, pilocytic astrocytoma, pituitary adenoma, premature neuroectodermal tumor, oncology, neurooncology, stroke, traumatic brain injury, cerebral edema | is listed by: One Mind Biospecimen Bank Listing | Tumor, Brain tumor, Cancer, Spinal tumor, Normal control | Available to researchers - not clear if internally or if provide specimens to the public | nlx_144398 | http://www.urmc.rochester.edu/neurosurgery/neurooncology/overview/research/ | SCR_005343 | University of Rochester Brain Tumor and Spinal Tumor Program | 2026-07-28 09:41:13 | 0 | |||||
|
University of Cincinnati Neuroscience Institute Resource Report Resource Website |
University of Cincinnati Neuroscience Institute (RRID:SCR_005345) | UCNI | data or information resource, topical portal, portal | Leading treatment, research and teaching center for complex neurological conditions based at the University Hospital and the UC College of Medicine. Its physicians and researchers have created national models for evidence-based treatment and research of complex conditions, including ischemic and hemorrhagic stroke, brain aneurysms, brain and spinal cord trauma, brain tumors, Parkinson's disease, epilepsy and seizure disorders, multiple sclerosis, trigeminal neuralgia, Alzheimer's disease and memory disorders, mood disorders, and neuromuscular disorders. UCNI includes a team of more than 100 experts from 15 specialties who collaborate across disciplines to provide the most comprehensive diagnoses and treatments possible. | neuroscience, brain, spinal cord, neurological condition | has parent organization: University of Cincinnati College of Medicine; Ohio; USA | Ischemic stroke, Hemorrhagic stroke, Brain aneurysm, Brain trauma, Spinal cord trauma, Brain tumor, Parkinson's disease, Epilepsy, Seizure disorder, Multiple Sclerosis, Trigeminal neuralgia, Alzheimer's disease, Memory disorder, Mood disorder, Neuromuscular disorder, Traumatic brain injury, Stroke, Tumor, Neurological condition | nlx_144401 | SCR_005345 | UC Neuroscience Institute | 2026-07-28 09:41:18 | 0 | |||||||
|
ChimerDB Resource Report Resource Website 10+ mentions |
ChimerDB (RRID:SCR_007596) | data or information resource, database | Knowledgebase of fusion transcripts collected from various public resources such as the Sanger CGP, OMIM, PubMed, and Mitelman's database. It is an alignment viewer to facilitate examining reliability of fusion transcripts and inferring functional significance., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | knowledge base, fusion transcript, transcript alignment, alignment viewer | has parent organization: Ewha Womans University; Seoul; South Korea | Tumor, Cancer | Korean Ministry of Education Science and Technology ; Gwangju Institute of Science and Technology ; Korean Ministry of Science and Technology R01-2008-000-20818-0; Korean Ministry of Science and Technology 2007-03983; National Core Research Center R15-2006-020; Korean Rural Development Administration 20070401034010 |
PMID:19906715 PMID:16381848 |
THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-02659 | http://genome.ewha.ac.kr/ChimerDB/ | SCR_007596 | 2026-07-28 09:41:51 | 29 | |||||
|
UMass Cancer Center Tissue and Tumor Bank Resource Report Resource Website 1+ mentions |
UMass Cancer Center Tissue and Tumor Bank (RRID:SCR_004447) | UMass Cancer Center Tissue and Tumor Bank | tissue bank, biomaterial supply resource, material resource | The UMass Cancer Center Tissue and Tumor Bank is a dynamic tissue procurement service: Collection, Storage, Annotation, and Distribution of Human Biologic Specimens. Our goal is to facilitate basic science, clinical research and translational studies by providing researchers with the ability to obtain and study human tissues using a dynamic collection, storage, annotation, and distribution service. * Fresh, diseased tissue is collected and processed immediately after surgery. ** When possible, surrounding healthy tissue is collected as a matched normal control. ** Anonymous, de-identified clinical and pathologic data are linked to the specimens in a secure database. * Bone marrow and blood specimens are collected and available as fresh cell isolates, frozen cell isolates or unprocessed. * A variety of services are available including routine histology, fresh tissue for cell culture, frozen sections, as well as DNA and RNA extraction. * Specific study needs can be met. * Consultation during study design is available and recommended. Contact Us * Assistance in the IRB approval process is offered. ** New: IRB approval is required only if you need identifiable private clinical information and/or patient follow-up for your study. The UMass Cancer Center Tissue and Tumor Bank is an open access biorepository. Specimens are available to investigators both internal and external to UMass. The Tumor Bank ships specimens to researchers worldwide. Please contact us to determine if we have specimens that meet your research needs. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Massachusetts Medical School; Massachusetts; USA |
Cancer, Tumor | nlx_44171 | SCR_004447 | Cancer Center Tissue and Tumor Bank, Cancer Center Tissue Tumor Bank, UMass Cancer Center Tissue Tumor Bank | 2026-07-28 09:41:02 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the nidm-terms Resources search. From here you can search through a compilation of resources used by nidm-terms and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that nidm-terms has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on nidm-terms then you can log in from here to get additional features in nidm-terms such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into nidm-terms you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
